top of page

Iris Zemzoum President, Novartis Asia Pacific, Middle East & Africa (APMA)

  • Sep 22, 2022
  • 1 min read

Updated: Aug 26, 2024




22 September 2022


In an interview with PharmaBoardroom, Iris Zemzoum of Novartis Asia Pacific, Middle East & Africa (APMA) outlines the devastating impact of cardiovascular disease (CVD) as well as Novartis' multipronged approach to overcoming healthcare disparities across a diverse region that is home to half the world's population.


Read the article here.


bottom of page